SmallCaps
ASX:COHHealth Care Equipment & ServicesHealth Care Equipment

Cochlear Ltd

$124.960
Day Range
$121.450 – $125.070
52 Week Range
$88.740 – $319.560
Volume
0.00
Avg Volume (10D)
580.21K
Market Cap
$8.17B
P/E Ratio
21.08
Price Chart
Market Statistics
Open$124.960
Previous Close$124.960
Day High$125.070
Day Low$121.450
52 Week High$319.560
52 Week Low$88.740
Valuation
Market Cap8.17B
Shares Outstanding65.40M
P/E Ratio (Annual)21.08
P/E Ratio (TTM)23.73
Dividend Yield3.44%
Price to Book4.22
Trading Activity
Volume0.00
Value Traded0.00
Performance
1 Day3.83%
5 Day5.87%
13 Week-27.50%
52 Week-58.54%
YTD-52.06%
Technical Indicators
RSI (14)68.76
50-Day SMA$103.264
200-Day SMA$207.866
Latest News
Gold surge helps ASX to a weekly rise
Hot Topics

Gold surge helps ASX to a weekly rise

Gold rally fuels ASX weekly gain as miners surge; Catalyst Metals +19%, Genesis Minerals +16%, Newmont +5%, Fortescue slips on China move.

Weekly wrap: ASX loses steam amid hairy chested war rhetoric
Hot Topics

Weekly wrap: ASX loses steam amid hairy chested war rhetoric

ASX slips as Trump-Iran tension persists; IGO sinks 18% on lithium gloom, while energy stocks rally; weekly loss about 1.8%.

Cochlear rejects ACCC’s concerns over Oticon Medical acquisition, Santos loses Barossa offshore drilling appeal and Beach Energy submits counterproposal
ASX 200

Cochlear rejects ACCC’s concerns over Oticon Medical acquisition, Santos loses Barossa offshore drilling appeal and Beach Energy submits counterproposal

Australia’s competition watchdog, the Australian Competition and Consumer Commission (ACCC) declared it has “significant preliminary competition concerns” regarding Cochlear’s (ASX: COH) proposed $170 million acquisition of Oticon Medical. Cochlear and Oticon Medical manufacture and distribute non-surgical bone conduction devices, surgical bone anchored devices, and cochlear implant hearing devices. The ACCC released a statement fearing the […]

COVID-19 pandemic hits Cochlear and Suncorp
Hot Topics

COVID-19 pandemic hits Cochlear and Suncorp

The COVID-19 pandemic has continued to have a big impact on Australian companies, with the latest being Cochlear (ASX: COH) and Suncorp (ASX: SUN). Cochlear chief executive officer Dig Howitt said it was still too early to predict the true impact of coronavirus on the hearing implant maker, which is in “unchartered territory” due to […]